Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BAC vs GSK✓SelectedUSD · GSKBAC vs GSK performance historyLatest closeAs of+1.01%11/13
Stock and ETF performance explorer

BAC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.9%
GSK return
+65.8%
Excess return
+32.1%
Maximum drawdown
-27.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.0%+0.5%+0.5%+1.0%
7D+3.2%+1.1%+2.1%+3.2%
30D-0.7%+6.3%-7.1%-1.1%
3M-20.0%+1.8%-21.8%-20.1%
6M+3.4%+1.7%+1.8%+3.3%
YTD-5.7%+6.5%-12.3%-5.9%
1Y-1.4%+9.5%-10.9%-1.7%
3Y+97.9%+65.3%+32.6%+94.3%
All+97.9%+65.8%+32.1%+94.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling